The store will not work correctly when cookies are disabled.
1-(azetidin-1-yl)-2-(6-(3-(trifluoromethyl)phenyl)-1H-pyrrolo[3,2-b]pyridin-1-yl)ethanone
ID: ALA4515350
PubChem CID: 124176023
Max Phase: Preclinical
Molecular Formula: C19H16F3N3O
Molecular Weight: 359.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Cn1ccc2ncc(-c3cccc(C(F)(F)F)c3)cc21)N1CCC1
Standard InChI: InChI=1S/C19H16F3N3O/c20-19(21,22)15-4-1-3-13(9-15)14-10-17-16(23-11-14)5-8-25(17)12-18(26)24-6-2-7-24/h1,3-5,8-11H,2,6-7,12H2
Standard InChI Key: LHYFLTYKAZTAJM-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
26.3179 -23.0836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3168 -23.9031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0248 -24.3121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0230 -22.6747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7317 -23.0800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7364 -23.8986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5165 -24.1470 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9938 -23.4819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5087 -22.8225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7735 -24.9227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5738 -25.0880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8309 -25.8637 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.1171 -24.4775 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.6087 -24.3111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9030 -23.9005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1954 -24.3079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1943 -25.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9067 -25.5350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6113 -25.1252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9089 -26.3521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2023 -26.7627 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.6178 -26.7588 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.9037 -27.1654 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
29.4620 -26.5898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1923 -26.9566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5590 -26.2263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
2 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
18 20 1 0
20 21 1 0
20 22 1 0
20 23 1 0
12 24 1 0
24 25 1 0
25 26 1 0
26 12 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.35 | Molecular Weight (Monoisotopic): 359.1245 | AlogP: 3.95 | #Rotatable Bonds: 3 |
Polar Surface Area: 38.13 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.33 | CX LogP: 3.00 | CX LogD: 3.00 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.71 | Np Likeness Score: -1.89 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |